Exotech Bio Solutions

Biodegradable Superabsorbent Polymers

Health Tech & Life Sciences
Acquired (Inactive) by PolyGreen on Jan 2016 - closed due to acquisition

Company Overview

Snapshot

Founded in December 1999, Exotech Bio Solutions operates with 1–10 employees. The company raised a total of $5 million across one disclosed funding round. Exotech Bio Solutions was acquired by PolyGreen in January 2016.

Business overview

Exotech Bio Solutions is a chemical company based in Israel that specializes in the development of biodegradable and superabsorbent polymers. Its core technology, the ethylene-bis-stearamide (EBS) compound, is designed to fully biodegrade within two months. The company offers products for personal hygiene, agriculture, and nursing applications, with potential uses including biodegradable diapers and diet pills. Exotech Bio Solutions operates within the Health Tech & Life Sciences sector, specifically targeting the Pharmaceuticals market.

Strategic signal

In January 2016, Exotech Bio Solutions was acquired by PolyGreen. This acquisition signals a strategic consolidation within the biodegradable materials market, indicating the value placed on Exotech's innovative polymer technology and its potential applications in sustainable products.

Company Intelligence Q&A

What is Exotech Bio Solutions' primary focus?
Exotech Bio Solutions develops biodegradable and superabsorbent polymers for applications in personal hygiene, agriculture, and nursing, with potential uses in products like biodegradable diapers and diet pills.
When was Exotech Bio Solutions founded?
Exotech Bio Solutions was founded in December 1999.
What was a significant corporate milestone for Exotech Bio Solutions?
Exotech Bio Solutions was acquired by PolyGreen in January 2016, leading to its inactive status.
What is the key innovation of Exotech Bio Solutions?
Exotech Bio Solutions' key innovation is the ethylene-bis-stearamide (EBS) compound, which is designed to completely biodegrade in two months.
What is the total capital raised by Exotech Bio Solutions?
Exotech Bio Solutions raised a total of $5 million across one disclosed funding round.